TNFAIP6 and inflammatory bowel disease: As a key anti-inflammatory cytokine released from MSCs, TSG-6 mediates the therapeutic effects of MSCs in IBD through dual mechanisms of immune modulation and tissue regeneration (Zhang et al. 2021; Yang et al. 2019).